Deferasirox marketed by Cipla USA Inc. under NDC Code 69097-560-53
NDC Code(s) : 69097-550-53, 69097-560-53, 69097-570-53
Packager : Cipla USA Inc.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
Deferasirox
Deferasirox GRANULE |
|
|
|
|
|
|
Deferasirox
Deferasirox GRANULE |
|
|
|
|
|
|
Deferasirox
Deferasirox GRANULE |
|
|
|
|
|
|
PRINCIPAL DISPLAY PANEL
NDC 69097-550-53
Deferasirox Oral Granules, 90 mg
Rx Only
Cipla USA, Inc.
Carton Label (30 Sachets in 1 Carton)
![90 mg](/xml/31c5a91f-e901-418b-a519-779a0c245477/ce7e02d0-319e-4a5b-87e1-c6550ab4322c-03.jpg)
NDC 69097-560-53
Deferasirox Oral Granules, 180 mg
Rx Only
Cipla USA, Inc.
Carton Label (30 Sachets in 1 Carton)
![90 mg](/xml/31c5a91f-e901-418b-a519-779a0c245477/ce7e02d0-319e-4a5b-87e1-c6550ab4322c-04.jpg)
NDC 69097-570-53
Deferasirox Oral Granules, 360 mg
Rx Only
Cipla USA, Inc.
Carton Label (30 Sachets in 1 Carton)
![90 mg](/xml/31c5a91f-e901-418b-a519-779a0c245477/ce7e02d0-319e-4a5b-87e1-c6550ab4322c-05.jpg)
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.